Dr. Rockson is interested in the biology of lymphatic function in health and disease and has a specific interest in the lymphedema therapeutics and have created animal models to achieve high throughput screening.

Dr. Berry's clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process.

Dr. Jamie Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.

Dr. Valdez's group's research focuses in improving our diagnostic ability in common pediatric infectious and inflammatory conditions through optics.

The primary aim of Dr. James's lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.

Dr. Tawfik's overall research interest is to understand how the immune system interacts with the nervous system after injury to promote the transition from acute to chronic pain.

Dr. Sledge's group is evaluating new means of examining circulating tumor cells in patients with breast cancer with the intent of improving therapy and reducing drug resistance and is also studying the use of a "Big Data" approach to breast cancer through the Oncoshare project, which brings together multiple clinical databases.

Dr. Berek's research interests include drug development for ovarian cancer: he is currently studying levels of GBP1 expression, target protein levels, and the drug effect.

Dr. Hoffman's laboratory is interested in examining the role of insulin-like growth factors (IGF) in normal physiology and in oncogenesis and is studying the molecular biology of IGF with an emphasis on long range chromatin interactions.

Dr. Kothary’s clinical practice primarily focuses on percutaneous and endovascular therapies for primary and metastatic liver cancer, and er research interests lie in radiogenomics and in the use of advanced imaging in the diagnosis and treatment of hepatocellular carcinoma (HCC).